Full-Time

Medical Director

Clinical Development

Confirmed live in the last 24 hours

GRAIL

GRAIL

1,001-5,000 employees

Blood tests for early cancer detection

Biotechnology
Healthcare

Compensation Overview

$245k - $327kAnnually

Senior

Menlo Park, CA, USA

Hybrid position based in Menlo Park, CA.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Google Cloud Platform
Requirements
  • MD required, board certified/board eligible in oncology strongly preferred
  • 2 + years of clinical practice experience
  • 3 + years of experience in a diagnostics or pharmaceutical Clinical Development setting
  • Experience in designing and conducting clinical studies, particularly registrational and/or clinical utility studies for reimbursement
  • Prior experience in a medical monitoring role strongly preferred, including medical case review and assessment of adverse event reports to determine seriousness and reportability
  • Experience in oncology, genomics, diagnostics, cell-free DNA-based applications, or similar applied medical fields is strongly preferred
  • Familiarity with the development of real-world evidence from real-world data (e.g., healthcare claims or electronic health records)
  • Knowledge of regulatory requirements (e.g. ICH, GCP, HIPAA, ISO) and a commitment to compliance
  • Experience authoring Standard Operating Procedures (SOPs) and similar documents in support of the role and responsibilities of a Medical Director
  • Excellent verbal and written communication skills, including clear and confident presentation skills
  • Ability to network and partner within external investigator and national organizations
  • Results oriented and strong attention to detail
  • Strong leadership and collaboration skills
Responsibilities
  • Act as a medical monitor for designated clinical and/or real-world evidence studies, serving as a member of the cross-functional clinical study management team
  • Issue queries and communicate with clinical study site staff to ensure completeness and accuracy of clinical data
  • Prepare and review answers to safety queries from regulatory authorities and IRBs as needed
  • Collaborate with other medical directors, clinical scientists, clinical data managers, biostatisticians, data scientists, and other functional stakeholders on the design, conduct, and analysis of clinical studies
  • Collaborate with colleagues from biostatistics to develop statistical analysis plans and serve as a co-author on clinical study reports and other study deliverables
  • Contribute to the development and preparation of regulatory documents
  • Provide scientific and medical support for publications and presentations to ensure scientific and medical accuracy and cross-functional alignment
  • Support efforts to advance clinical development and scientific research plans (review and interpretation of study data; engagement of key opinion leaders; providing strategic and scientific input to study-level and program-level teams)
  • Develop formal networks with external investigators and thought leaders to support clinical study programs
  • Ensure compliance with industry regulations, policies, guidelines and standards

GRAIL focuses on improving cancer detection through advanced blood tests that identify cancer at its earliest stages, enhancing treatment success rates. The company utilizes high-intensity sequencing to analyze tumor genome data, employing algorithms and deep learning to extract actionable information for early cancer detection. GRAIL differentiates itself from competitors by conducting large-scale clinical studies to ensure the effectiveness and reliability of its tests. The primary goal is to reduce global cancer mortality by enabling early diagnosis, making the disease more treatable.

Company Stage

N/A

Total Funding

$1.8B

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

-5%

1 year growth

1%

2 year growth

5%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful completion of large-scale clinical trials like PATHFINDER 2 and NHS-Galleri could solidify GRAIL's reputation and lead to widespread adoption of its Galleri test.
  • Partnerships with healthcare providers like CarePoint and WVU Medicine enhance GRAIL's market penetration and credibility in the healthcare sector.
  • The spin-off from Illumina and potential listing on Nasdaq could provide GRAIL with increased financial resources and market visibility.

What critics are saying

  • The high cost and complexity of large-scale clinical trials could strain GRAIL's financial resources and delay product rollouts.
  • Dependence on partnerships and collaborations for market penetration may limit GRAIL's control over its growth trajectory.

What makes GRAIL unique

  • GRAIL leverages high-intensity sequencing and deep learning to analyze vast amounts of tumor genome data, setting it apart from traditional cancer detection methods.
  • The company's focus on large-scale clinical studies, such as PATHFINDER 2 and NHS-Galleri, ensures robust clinical validation and performance evidence for its Galleri test.
  • GRAIL's potential to expand into direct-to-consumer sales could significantly broaden its market reach, unlike many competitors who remain focused on B2B models.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Outstanding People - Join a team of passionate and dedicated professionals, committed to collaboration, education, and proactive problem-solving.

Strong Compensation - We offer competitive salaries and savings plans to provide for long-term financial planning.

Complete Health Coverage - Take advantage of comprehensive health coverage, with medical, dental and vision, to keep you and your family healthy.

Work-Life Balance - Make everyday life more manageable with flexible time off – we trust you to do great work and take time for yourself.